Moxetumomab pasudotox-tdfk Intravenous and Stadol
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Stadol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: butorphanol
Brand name: Stadol NS, Stadol
Synonyms: Stadol NS (nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Stadol injection
- Moxetumomab pasudotox-tdfk Intravenous-Stadol NS nasal
- Moxetumomab pasudotox-tdfk Intravenous-Stagesic
- Moxetumomab pasudotox-tdfk Intravenous-Stahist AD
- Moxetumomab pasudotox-tdfk Intravenous-Stahist AD (Chlorcyclizine and Pseudoephedrine Liquid)
- Moxetumomab pasudotox-tdfk Intravenous-Stahist AD (Chlorcyclizine and Pseudoephedrine Tablets)
- Stadol-Moxifloxacin
- Stadol-Moxifloxacin (Systemic)
- Stadol-Moxifloxacin Hydrochloride
- Stadol-Moxifloxacin Injection
- Stadol-Moxifloxacin Intravenous
- Stadol-Moxifloxacin Tablets